TITLE

Relapsing hepatitis a as an indication for liver transplantation

AUTHOR(S)
Troy, Tara N; Levitsky, Josh; Te, Helen S; Cohen, Stanley M
PUB. DATE
September 2003
SOURCE
American Journal of Gastroenterology;Sep2003 Supplement, Vol. 98, pS165
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
An abstract of the article "Relapsing Hepatitis A as an Indication for Liver Transplantation," by Tara N. Troy, Josh Levitsky, Helen S. Te, and Stanley M. Cohen is presented.
ACCESSION #
66955018

 

Related Articles

  • Infected livers used for transplants. Lund, Amy E. // Journal of the American Dental Association (JADA);Sep99, Vol. 130 Issue 9, p1276 

    Reports on the use of hepatitis C (HCV)-infected livers in liver transplants. Comparison of survival rates among patients receiving healthy liver and HCV-infected liver; Transplantation of HCV-infected livers due to the shortage of healthy livers.

  • Correction.  // New England Journal of Medicine;4/5/2012, Vol. 366 Issue 14, p1356 

    A correction to the article "Early Liver Transplantation for Severe Alcoholic Hepatitis Correspondence" that was published in a 2012 issue is presented.

  • Survival after liver transplantation for chronic hepatitis. Dale, David C.; Federman, Daniel D. // Cortlandt Forum;01/25/98, Vol. 11 Issue 1, p18 

    Discloses survival rates in patients with chronic hepatitis B who undergo liver transplantation. Therapy with high-dose hepatitis B immune globulin after transplantation.

  • Introduction. Manns, Michael P.; Weissenborn, Karin // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p1 

    The article discusses various reports published within the issue, including one on the pathophysiology of hepatic encephalopathy, and neurological complications after liver transplantation.

  • Outcome and Management of Hepatitis C in Liver Transplant Recipients. Chan, Susan E.; Rosen, Hugo R. // Clinical Infectious Diseases;9/15/2003, Vol. 37 Issue 6, p807 

    Focuses on the outcome and management of hepatitis C (HCV) in liver transplant recipients. Limitations of antiviral therapy in both efficacy and tolerability; Implications of the shortage of organs available; Demonstration of significantly higher mortality among HCV-positive liver transplanted...

  • Liver Transplantation and Hepatitis B. Poterucha, John J.; Wiesner, Russell H. // Annals of Internal Medicine;05/15/97, Vol. 126 Issue 10, p805 

    Editorial. Examines the outcome of liver transplantation among hepatitis B patients. Factors influencing outcome; Therapies indicated for preventing the recurrence of hepatitis B among post-liver transplantation patients; Clinical trials for ganciclovir treatment of recurrent hepatitis B.

  • Living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months. Hasegawa, Kiyoshi; Hashimoto, Etsuko; Kanai, Naoko; Ogawa, Miho; Naritomi, Takuma; Taniai, Makiko; Takasaki, Ken; Hayashi, Naoaki // Journal of Gastroenterology;2001, Vol. 36 Issue 9, p637 

    We report a case of living-related partial liver transplantation for decompensated hepatitis B without reactivation of hepatitis B in the following 30 months, and we analyze the factors that indicate a favorable prognosis for transplantation. The 42-year-old female patient received continuously...

  • Prognostic Factors in Severe Exacerbation of Chronic Hepatitis B. Man-Fung Yuen; Sablon, Erwin; Chee-Kin Hui; Tak-Ming Li; He-Jun Yuan; Ka-Ho Wong, Danny; Doutreloigne, Joke; Bogaerts, Veerle; Chun-Yu Wong, Benjamin; Sheung-Tat Fan; Ching-Lung Lai // Clinical Infectious Diseases;4/15/2003, Vol. 36 Issue 8, p979 

    Identifies prognostic factors for patients with severe exacerbation of chronic hepatitis B infection and examines the role of precore and core promoter mutations in such exacerbations. Need for patients with severe exacerbation of hepatitis B with poor prognostic factors to be considered for...

  • Prevention of Recurrence of Hepatitis B Virus Infection after Liver Transplantation. Sanchez Fueyo, A. // BioDrugs;2000, Vol. 13 Issue 3, p189 

    Hepatitis B virus (HBV) infection is still an important cause of cirrhosis, hepatocellular carcinoma and acute liver failure worldwide, and orthotopic liver transplantation (OLT) is the only effective treatment for many of these conditions. Until recently, however, OLT in patients with HBV...

  • Recurrence of hepatitis C after liver transplantation is associated with increased systemic IL-10 levels. Sheiner, Patricia A.; Florman, Sander S.; Emre, Sukru; Fishbein, Thomas; Schwartz, Myron E.; Miller, Charles M.; Borosca, Peter // Mediators of Inflammation;Feb2001, Vol. 10 Issue 1, p37 

    BACKGROUND: Recurrence of hepatitis C after liver transplantation is an almost universal occurrence. T-cell derived cytokines have an important role in the development of liver damage associated with chronic hepatitis C, their post-transplant levels, however, have not been correlated with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics